Literature DB >> 15069718

In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells.

Feng Xu1, Ying-Jiang Ye, Shan Wang.   

Abstract

AIM: The prevention of recurrence of colon cancer (CC) after operation is very important for improvement of the prognosis of CC patients, especially those with micro-metastasis. The generation of fused cells between dendritic cells (DCs) and tumor cells maybe an effective approach for tumor antigen presentation in immunotherapy. In this study, we fused human colon caner SW480 cells and human peripheral blood - derived DCs to induce an antitumor activity against human CC.
METHODS: CC SW480 cells and human peripheral blood - derived DCs were fused with 500 mL/L polyethylene glycol (PEG).
RESULTS: The specific T cell responses activated by fusion cells (FCs), were observed. About 100 mL/L to 160 mL/L of the PEG-treated non-adherent cells with fluorescences were considered to be dendritomas that highly expressed the key molecules for antigen presentation in our five cases. In vitro studies showed that fusions effectively activated CD8(+) T lymphocytes to secrete interferon-gamma. The early apoptotic ratio of the colon cancer SW480 cells was higher than that of controls, which was affected by cytotoxic T lymphocytes (CTLs) stimulated by dendritomas.
CONCLUSION: The data indicate that fusion of tumor cells with DCs is an attractive strategy to induce tumor rejection.

Entities:  

Mesh:

Year:  2004        PMID: 15069718      PMCID: PMC4656353          DOI: 10.3748/wjg.v10.i8.1162

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Phototoxicity of the fluorescent membrane dyes PKH2 and PKH26 on the human hematopoietic KG1a progenitor cell line.

Authors:  D J Oh; G M Lee; K Francis; B O Palsson
Journal:  Cytometry       Date:  1999-08-01

2.  Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells.

Authors:  J Zhang; J K Zhang; S H Zhuo; H B Chen
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.

Authors:  S Homma; G Toda; J Gong; D Kufe; T Ohno
Journal:  J Gastroenterol       Date:  2001-11       Impact factor: 7.527

4.  DNA-based immunization by in vivo transfection of dendritic cells.

Authors:  C Condon; S C Watkins; C M Celluzzi; K Thompson; L D Falo
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

5.  In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.

Authors:  A D Michelson; M R Barnard; H B Hechtman; H MacGregor; R J Connolly; J Loscalzo; C R Valeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 6.  Dendritic cells presenting tumor antigen.

Authors:  M R Shurin
Journal:  Cancer Immunol Immunother       Date:  1996-11       Impact factor: 6.968

7.  Immunotherapy. Fusion induces tumour rejection.

Authors:  I Hart; C Colaco
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

8.  Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

Authors:  T Kikuchi; Y Akasaki; M Irie; S Homma; T Abe; T Ohno
Journal:  Cancer Immunol Immunother       Date:  2001-09       Impact factor: 6.968

9.  Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.

Authors:  J Wang; S Saffold; X Cao; J Krauss; W Chen
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

10.  Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.

Authors:  A Porgador; E Gilboa
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?

Authors:  Yang Zhou; Jun-Ting Cheng; Zi-Xian Feng; Ying-Ying Wang; Ying Zhang; Wen-Qi Cai; Zi-Wen Han; Xian-Wang Wang; Ying Xiang; Hui-Yu Yang; Bing-Rong Liu; Xiao-Chun Peng; Shu-Zhong Cui; Hong-Wu Xin
Journal:  World J Gastrointest Oncol       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.